Summit

Financial Times Global Pharma and Biotech Summit

Name: Financial Times Global Pharma and Biotech Summit
Location: London, UK

A senior leadership summit in London addressing pharmaceutical research, drug development, commercial strategy, and healthcare policy.

When: November, Early November
Where: London, UKView on Google Maps
Format: Hybrid
Organiser: FT Live
Region: Global
Scale: About 800 attendees
Founded: 2014

The Signal

The Financial Times Global Pharma and Biotech Summit is organized by FT Live and held in London. This executive meeting convenes global pharmaceutical chief executives, policymakers, and biotech founders. Panel sessions focus on drug pricing, geopolitical supply chain risks, and artificial intelligence in drug discovery. For healthtech operators, it highlights how major pharmaceutical companies intend to deploy digital technologies in clinical trials.

What to expect

AI driven drug discovery
Global drug pricing policies
Clinical trial modernization

Who is in the room

Pharmaceutical chief executives, biotechnology founders, health policy experts, and institutional investors attend.

Background

The summit was established by the Financial Times to provide a high level, journalist led forum for the life science sector. It has grown to be a key calendar event for global healthcare executives.

Official event site